Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 210

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

Open access
Andreano, Emanuele, Nicastri, Emanuele, Paciello, Ida, Pileri, Piero, Manganaro, Noemi, Piccini, Giulia, Manenti, Alessandro, Pantano, Elisa, Kabanova, Anna, Troisi, Marco, Vacca, Fabiola, Cardamone, Dario, De Santi, Concetta, Torres, Jonathan L., Ozorowski, Gabriel, Benincasa, Linda, Jang, Hyesun, Di Genova, Cecilia, Depau, Lorenzo, Brunetti, Jlenia, Agrati, Chiara, Capobianchi, Maria Rosaria, Castilletti, Concetta, Emiliozzi, Arianna, Fabbiani, Massimiliano, Montagnani, Francesca, Bracci, Luisa, Sautto, Giuseppe, Ross, Ted M., Montomoli, Emanuele, Temperton, Nigel, Ward, Andrew B., Sala, Claudia, Ippolito, Giuseppe, Rappuoli, Rino · 2021 · Cell

Abstract

Human monoclonal antibodies are safe, preventive, and therapeutic tools that can be rapidly developed to help restore the massive health and economic disruption caused by the coronavirus disease 2019 (COVID-19) pandemic. By single-cell sorting 4,277 SARS-CoV-2 spike protein-specific memory B cells from 14 COVID-19 survivors, 453 neutralizing antibodies were identified. The most potent neutralizing antibodies recognized the spike protein receptor-binding domain, followed in potency by antibodies that recognize the S1 domain, the spike protein trimer, and the S2 subunit. Only 1.4% of them neutralized the authentic virus with a potency of 1–10 ng/mL. The most potent monoclonal antibody, engineered to reduce the risk of antibody-dependent enhancement and prolong half-life, neutralized the authentic wild-type virus and emerging variants containing D614G, E484K, and N501Y substitutions. Prophylactic and therapeutic efficacy in the hamster model was observed at 0.25 and 4 mg/kg respectively in absence of Fc functions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2021.02.035

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 210

Metadata

Authors
Andreano, E., Nicastri, E., Paciello, I., Pileri, P., Manganaro, N., Piccini, G., Manenti, A., Pantano, E., Kabanova, A., Troisi, M., Vacca, F., Cardamone, D., De Santi, C., Torres, J. L., Ozorowski, G., Benincasa, L., Jang, H., Di Genova, C., Depau, L., Brunetti, J., Agrati, C., Capobianchi, M. R., Castilletti, C., Emiliozzi, A., Fabbiani, M., Montagnani, F., Bracci, L., Sautto, G., Ross, T. M., Montomoli, E., Temperton, N., Ward, A. B., Sala, C., Ippolito, G., & Rappuoli, R.
Venue
Cell
Publisher
Elsevier BV
Published
2021-04
Volume
184
Issue
7
Pages
1821-1835.e16
ISSN
0092-8674 (ISSN-L)
OpenAlex
W3131871667
Cited by
210
References
24
FWCI
13.47
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. https://app.cochat.ai/papers/10.1016/j.cell.2021.02.035
The paper
Andreano, E., Nicastri, E., Paciello, I., Pileri, P., Manganaro, N., Piccini, G., Manenti, A., Pantano, E., Kabanova, A., Troisi, M., Vacca, F., Cardamone, D., De Santi, C., Torres, J. L., Ozorowski, G., Benincasa, L., Jang, H., Di Genova, C., Depau, L., . . . Rappuoli, R. (2021). Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell. https://doi.org/10.1016/j.cell.2021.02.035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.